MANOR BROOK PMS — All Prescriptions & Medications — Page 3
Practice Code: G83001 | LONDON, SE3 0EN
Showing results 101-150 of 606
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Warfarin sodium | 463 | 32.6K | £1.2K | -1.8% vs avg |
| Hydrocortisone | 456 | 13.3K | £2.4K | +1.7% vs avg |
| Memantine hydrochloride | 446 | 5,614 | £590 | +35.0% ▲ |
| Methylphenidate hydrochloride | 445 | 24.0K | £14.3K | +72.3% ▲ |
| 444 | 5,494 | £2.2K | +77.9% ▲ | |
| Betamethasone valerate | 441 | 37.2K | £1.9K | +14.5% ▲ |
| Risperidone | 437 | 5,056 | £1.2K | +72.7% ▲ |
| Melatonin | 435 | 23.3K | £8.4K | +30.8% ▲ |
| Codeine phosphate | 433 | 38.2K | £1.3K | -39.7% ▼ |
| Morphine sulfate | 430 | 51.6K | £2.4K | -34.4% ▼ |
| Lactulose | 424 | 211.5K | £2.3K | +28.8% ▲ |
| Quinine sulfate | 418 | 9,296 | £1.5K | +44.4% ▲ |
| Tramadol hydrochloride | 411 | 33.9K | £2.0K | -42.7% ▼ |
| Diltiazem hydrochloride | 408 | 15.9K | £3.5K | +32.9% ▲ |
| Methenamine hippurate | 403 | 17.5K | £4.6K | +343.0% ▲ |
| Carbamazepine | 399 | 98.1K | £8.7K | +34.4% ▲ |
| Insulin aspart | 393 | 3,032 | £20.8K | +3.2% ▲ |
| Mometasone furoate | 393 | 449 | £3.5K | -2.1% ▼ |
| Donepezil hydrochloride | 391 | 5,558 | £239 | +26.7% ▲ |
| Oxybutynin | 389 | 17.5K | £2.8K | +104.2% ▲ |
| Mesalazine (Systemic) | 386 | 50.0K | £24.3K | +61.1% ▲ |
| Felodipine | 383 | 15.7K | £2.5K | -35.5% ▼ |
| Other emollient preparations | 379 | 227.2K | £3.2K | -36.9% ▼ |
| Combined ethinylestradiol 30mcg | 378 | 31.0K | £1.8K | +36.1% ▲ |
| Irbesartan | 375 | 12.1K | £504 | +53.9% ▲ |
| 367 | 1,104 | £38.8K | -32.7% ▼ | |
| Clarithromycin | 362 | 6,390 | £1.6K | +47.5% ▲ |
| Alginic acid compound preparations | 349 | 183.4K | £2.9K | -40.4% ▼ |
| Fludrocortisone acetate | 347 | 4,134 | £654 | +228.9% ▲ |
| Bumetanide | 343 | 7,807 | £787 | +25.9% ▲ |
| Buprenorphine | 339 | 1,538 | £5.4K | -7.5% ▼ |
| Letrozole | 339 | 12.9K | £1.2K | +81.5% ▲ |
| Clobetasone butyrate | 322 | 19.6K | £1.8K | +57.8% ▲ |
| 316 | 5,446 | £3.3K | -52.4% ▼ | |
| Pravastatin sodium | 310 | 9,598 | £475 | -4.5% ▼ |
| Paroxetine hydrochloride | 310 | 12.4K | £663 | +66.1% ▲ |
| Lisdexamfetamine dimesylate | 305 | 8,766 | £21.6K | +155.4% ▲ |
| Estradiol | 305 | 8,042 | £3.9K | +13.1% ▲ |
| Nefopam hydrochloride | 300 | 26.0K | £1.2K | +165.2% ▲ |
| Insulin glargine | 294 | 1,640 | £15.9K | +3.5% ▲ |
| Methotrexate | 287 | 7,844 | £695 | -11.8% ▼ |
| Hydroxychloroquine sulfate | 269 | 10.3K | £563 | +38.9% ▲ |
| Betahistine hydrochloride | 259 | 14.5K | £537 | +8.5% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 258 | 26.6K | £2.0K | +14.2% ▲ |
| Carvedilol | 256 | 11.0K | £391 | +125.6% ▲ |
| Fluticasone furoate/vilanterol | 256 | 396 | £9.2K | +65.4% ▲ |
| Montelukast | 255 | 7,637 | £441 | -62.8% ▼ |
| Glyceryl trinitrate | 243 | 785 | £734 | +2.7% ▲ |
| Loperamide hydrochloride | 237 | 29.7K | £1.5K | +1.8% vs avg |
| Trimethoprim | 237 | 7,688 | £425 | +16.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.